Clinical Trials

Toll-Free: 866.320.4573

Call Us Toll Free:

866.223.2273 x1234

Danazol in Treating Patients With Advanced or Recurrent Endometrial Cancer

Study:

Phase II Study of Danazol in Advanced or Recurrent Endometrial Cancer

Rationale:

Hormone therapy may be an effective treatment for endometrial cancer.

Purpose:

Phase II trial to study the effectiveness of danazol in treating patients with advanced or recurrent endometrial cancer.

Study Status: Completed

Recruiting:
n/a

Condition Intervention Phase
Endometrial Cancer Drug: danazol Phase 2

Verified by Gynecologic Oncology Group July, 2004

Sponsored by: Gynecologic Oncology Group
Information provided by: National Cancer Institute (NCI)
ClinicalTrials.gov identifier: NCT00003946

Study Type: Interventional

Study Design: Primary Purpose: Treatment

Cleveland Clinic Cancer Center
Cleveland, Ohio 44195
United States

Allan Covens, MD., Study Chair

This information is abridged to display results relevant only to Cleveland Clinic. To see complete record visit ClinicalTrials.gov
  Information obtained from ClinicalTrials.gov on
Link to the current ClinicalTrials.gov record.